To investigate whether reactivated NPC cells in our model had acquired resistance to paclitaxel, we designed the following experimental schedule: NPC cells were reactivated as before, followed by a second induction of SOX1 to test for drug resistance (Fig. 3G). Here, SOX1 is linked to nasopharyngeal carcinoma.